Study Finds Dietary Luteolin May Mitigate Pesticide Toxicity in Nile Tilapia
Researchers at Cairo University evaluated the protective effects of dietary luteolin against thiamethoxam-induced liver and intestinal damage in Nile tilapia.
Key points
- Tested 180 Nile tilapia over a 14-day experimental period
- Evaluated thiamethoxam toxicity and luteolin protection
- Observed improvements in growth and reduced tissue damage with luteolin
A team of researchers from Cairo University and Al-Azhar University investigated the toxic impacts of the insecticide thiamethoxam on Nile tilapia and tested whether dietary supplementation with luteolin could offer protection. Published in Nature Health Sciences, the 14-day controlled trial assessed 180 fish divided into multiple experimental groups receiving varying levels of the pesticide and the flavonoid compound.
The findings indicate that exposure to the pesticide significantly impaired growth performance, reduced body weight, and triggered oxidative stress and tissue damage in both the liver and intestines. Specifically, treated fish showed elevated markers of cellular stress and inflammation alongside reduced antioxidant enzyme activity. However, groups receiving dietary luteolin at concentrations of 200 and 400 mg/kg demonstrated notable improvements in weight gain, restored antioxidant defenses, and reduced histopathological lesions in target organs.
What to know: While the results suggest that luteolin may help counteract specific chemical toxicities in aquaculture species, this remains an early-stage animal study. Readers are advised to consult qualified professionals regarding any health or dietary decisions.
Source Nature Health Sciences — nature.com/articles/s41598-026-72002-2 ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…